alg-000184
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 22, 2020 (NCT04536337)
Timeline
Indications
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06963710 | Phase 2 | Jul 15, 2025 | Aligos Therapeutics |
| NCT06672900 | Phase 1 | Jan 9, 2025 | Aligos Therapeutics |
| NCT04536337 | Phase 1 | Oct 22, 2020 | Aligos Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aligos Therapeutics | For profit | 3 | 3 | 2 | 2020 |
1 organizations
Page 1 / 1